{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:26:55Z","timestamp":1791563215917,"version":"4.3.4"},"reference-count":6,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["j. immunotherapy cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40425-018-0473-0","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T08:14:44Z","timestamp":1545120884000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-2744","authenticated-orcid":false,"given":"Cecilia","family":"Monge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyoung","family":"Maeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Brofferio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Apolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharath","family":"Sathya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Gulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijo","family":"Bilusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,12,18]]},"reference":[{"key":"473_CR1","doi-asserted-by":"crossref","unstructured":"Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, et al. Fulminant myocarditis with combination immune checkpoint blockade. N Engl J Med 2016;375:1749-1755. [PMID 27806233].","DOI":"10.1056\/NEJMoa1609214"},{"key":"473_CR2","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","volume":"391","author":"JJ Moslehi","year":"2018","unstructured":"Moslehi JJ, Salem JE, Sosman JA. Increased reporting of fatal immune checkpoint inhibitor associated myocarditis. Lancet. 2018;391:933.","journal-title":"Lancet"},{"key":"473_CR3","doi-asserted-by":"publisher","unstructured":"Mahmood SS, Fradley MG, Cohen JV, Anju Nohria KL, et al. Myocarditis in patients treated with immune checkpoint inhibitors. J. Am. Coll. Cardiol. 2018. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2018.02.037\n                    \n                  .","DOI":"10.1016\/j.jacc.2018.02.037"},{"key":"473_CR4","doi-asserted-by":"crossref","unstructured":"Wang DY, Okoye GD, Neilan TG, Johnson DB, Moslehi JJ. Cardiovascular toxicities associated with Cancer immunotherapies. Curr Cardiol Rep 2017;19:21. [PMID 28220466].","DOI":"10.1007\/s11886-017-0835-0"},{"key":"473_CR5","doi-asserted-by":"publisher","first-page":"e007598","DOI":"10.1161\/CIRCIMAGING.118.007598","volume":"11","author":"JA Pan","year":"2018","unstructured":"Pan JA, Yoo JL, Salerno M. Diagnostic performance of extracellular volume, native T1, and T2 mapping versus Lake Louise criteria by cardiac magnetic resonance for detection of acute myocarditis. Circ Cardiovasc Imaging. 2018;11:e007598. \n                    https:\/\/doi.org\/10.1161\/CIRCIMAGING.118.007598\n                    \n                  .","journal-title":"Circ Cardiovasc Imaging"},{"key":"473_CR6","doi-asserted-by":"publisher","unstructured":"Tay RY, Blackley E, McLean C, Moore, M. Succesful use of equine anti-thymocyte globulin (ATGAM) for fulminant myocardiutis secondary to nivolumab therapy. Br J Cancer2017;117 (7):921\u2013924. \n                    https:\/\/doi.org\/10.1038\/bjc.2017.253\n                    \n                  . Epub 2017 Aug10.","DOI":"10.1038\/bjc.2017.253"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0473-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40425-018-0473-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40425-018-0473-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T13:43:18Z","timestamp":1601041398000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1186\/s40425-018-0473-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/s40425-018-0473-0","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"4 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval waived in case reports.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication form has been obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"150"}}